Blog Post
A Commentary on the Draft EMA Annex 15 Changes in the Context of The CAI OR Program
Why the EMA Annex 15 Concept Paper Signals a Shift—and How It Aligns with The CAI Six Pillars of Operational Readiness In Feb 2026 the EMA with...
Read More
Blog Post
Navigating Regulatory Complexity in Life Sciences: Turning Compliance into a Strategic Advantage
As global regulations continue to evolve, life sciences companies are facing increasing pressure to meet stringent compliance requirements without slowing down innovation or compromising product...
Read More
Blog Post
Reflecting Again on GMP Requirements for Marketing Authorization Holder
In July 2021, the European Medicines Agency (EMA) published their reflection paper entitled “Good Manufacturing Practice (GMP ) and the Marketing Authorisation Holder (MAH)”. This...
Read More